ciltacabtagene autoleucel
janssen
['cilta-cel', 'cartitude-2']
new data from cartitude-2, cohort a shows promise for cilta-cel as an earlier line of tx in mutiple myeloma. read more from #asco22 here: 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.